REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Galagonya-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Galagonya-Pharma Gyogyszereszeti es Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Galagonya-Pharma Bt. is an enterprise based in Hungary. Its main office is in Kallo. It operates in the Pharmacies and Drug Stores industry. It was established on March 25, 1998. There are currently 4 (2024) people employed by Galagonya-Pharma Bt.. In 2023, the company reported a net sales revenue increase of 2.63%. Its’ total assets recorded a negative growth of 9.52%. Galagonya-Pharma Bt.’s net profit margin increased by 1.32% in 2023.

Headquarters
Kossuth L. u. 34.
Kallo; Nograd; Postal Code: 2175

Contact Details: Purchase the Galagonya-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Galagonya-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Galagonya-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Galagonya-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Galagonya-Pharma Bt. report to view the information.
Incorporation Date:
March 25, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Galagonya-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
2.63%▲
Total operating revenue
2.51%▲
Operating profit (EBIT)
N/A
EBITDA
203.17%▲
Net Profit (Loss) for the Period
55.2%▲
Total assets
-9.52%▼
Total equity
-10.54%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
1.32%▲
Return on Equity (ROE)
11.74%▲
Quick Ratio
-0.14%▼
Cash Ratio
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo